Details for New Drug Application (NDA): 215388
✉ Email this page to a colleague
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
Summary for 215388
| Tradename: | CLOPIDOGREL BISULFATE |
| Applicant: | Msn |
| Ingredient: | clopidogrel bisulfate |
| Patents: | 0 |
Pharmacology for NDA: 215388
| Mechanism of Action | Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 215388
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 215388 | ANDA | Preferred Pharmaceuticals Inc. | 68788-4173 | 68788-4173-3 | 30 TABLET, FILM COATED in 1 BOTTLE (68788-4173-3) |
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 215388 | ANDA | Preferred Pharmaceuticals Inc. | 68788-4173 | 68788-4173-6 | 60 TABLET, FILM COATED in 1 BOTTLE (68788-4173-6) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Sep 20, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
